Table 1 Correlation between BTK expression and clinicopathological variables of TSGH-OSCC patients (n = 70).

From: Inhibition of Bruton’s tyrosine kinase as a therapeutic strategy for chemoresistant oral squamous cell carcinoma and potential suppression of cancer stemness

Clinicopathological
variables
No. BTK   
High
expression
Low
expression
x2 p Value
Age, years
47 46 11 35 29.055 <0.001
å 47 24 22 2   
Gender
Male 63 29 34 0.312 0.576
Female 7 4 3   
T classification
T1–T2 46 17 29 4.147 0.042
T3–T4 24 15 9   
N classification
N0 36 16 20 0.048 0.826
N1–N3 34 16 18   
AJCC stage
I–II 24 7 17 4.030 0.045
III–VI 46 25 21   
CCRT
Yes 18 18 0 16.154 <0.001
No 52 24 28